Of Mice and Men, Women, and Children: Using Animal Models to Inform Tuberculosis Clinical Trials of Novel Agents
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Respiratory and Critical Care Medicine"
DOI: 10.1164/rccm.202112-2866ed
Abstract: In this issue of the Journal, Kaushik and colleagues (pp. 570–579) report on another iteration of the Grosset murine model of treatment for latent tuberculosis infection (LTBI) (1). Over decades, the utility of this model… read more here.
Keywords: tuberculosis; infection; months rifampin; model ... See more keywords
Health System Costs of Treating Latent Tuberculosis Infection With Four Months of Rifampin Versus Nine Months of Isoniazid in Different Settings
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Internal Medicine"
DOI: 10.7326/m19-3741
Abstract: BACKGROUND Four months of rifampin treatment for latent tuberculosis infection is safer, has superior treatment completion rates, and is as effective as 9 months of isoniazid. However, daily medication costs are higher for a 4-month… read more here.
Keywords: health; latent tuberculosis; months rifampin; tuberculosis infection ... See more keywords